跳至主要内容
临床试验/NCT05555225
NCT05555225已完成不适用

Methylome Study in Patients Affected With Sporadic Limb Malformations

University Hospital, Lille1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Differentially Methylated Regions

研究概览

简要总结

Some limb malformations are known to be sporadic (non hereditary). For these malformations, no molecular cause was identified, even after whole genome sequencing. Methylation of CpG islands is an epigenetic process which is usually not transmitted to the descents. We hypothesize that sporadic limb malformations may be due to a methylation anomaly. This study will include patients with Amelia or Femur Fibula Ulna Syndrome. With patients consent, we will study the methylome on DNA samples already available in our laboratory. Each patient sample will be paired to a control of same tissue, age and sex. By bioinformatics comparison, we will identify differentially methylated candidate regions.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Specific consent for this study
  • DNA available in the laboratory
  • For amelia : agenesia of 2 or 4 limbs
  • For Femur-Fibula-Ulna Syndrome : hypoplasia or agenesia of the femur uni or bilateral with hypoplasia or agenesia or bowing of the fibula and/or of the ulna

排除标准

  • No consent
  • No available DNA or poor quality of the DNA sample
  • Patient under tutorship
  • Pregnancy or nursing mother
  • Patient non covered by the French social security

结局指标

主要结局

Differentially Methylated Regions

时间窗: through study completion an average of 3 years

次要结局

未报告次要终点

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验